OBIO · Company research

Orchestra BioMed Holdings, Inc. Ordinary Shares (OBIO): Valuation Analysis

Available valuation snapshots and ratios; unavailable metrics remain blank.

RESEARCH CONTEXT

Understand the numbers

Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.

1records availableHealthcare

Valuation Analysis data

Database-backed records only

1 rows
valuation datepricemarket capenterprise valuepeforward pepegprice salesprice bookprice fcf
Oct 8, 20265.66$369,431,808.41341064808.41———3358.47098554545454557.2487355716668302—

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.